IRIS
MENNINI, FRANCESCO SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.292
EU - Europa 3.086
AS - Asia 766
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 8
OC - Oceania 5
Totale 30.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.248
IT - Italia 1.343
IE - Irlanda 467
DE - Germania 308
UA - Ucraina 307
CN - Cina 298
SG - Singapore 143
GB - Regno Unito 142
SE - Svezia 128
FR - Francia 110
VN - Vietnam 96
KR - Corea 91
RU - Federazione Russa 80
FI - Finlandia 61
CA - Canada 37
IR - Iran 29
IN - India 28
BE - Belgio 26
CH - Svizzera 23
PL - Polonia 22
NL - Olanda 19
HK - Hong Kong 16
TW - Taiwan 16
ES - Italia 12
JP - Giappone 10
PK - Pakistan 10
EU - Europa 9
BR - Brasile 8
PT - Portogallo 8
CZ - Repubblica Ceca 6
RO - Romania 6
IQ - Iraq 5
ZA - Sudafrica 5
AT - Austria 4
AU - Australia 4
MY - Malesia 4
PH - Filippine 4
BD - Bangladesh 3
CO - Colombia 3
DK - Danimarca 3
DM - Dominica 3
GR - Grecia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
HT - Haiti 2
HU - Ungheria 2
ID - Indonesia 2
MK - Macedonia 2
TH - Thailandia 2
TR - Turchia 2
AR - Argentina 1
BO - Bolivia 1
CU - Cuba 1
GH - Ghana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
MX - Messico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 30.182
Salva come PNG Salva come JPEG
Città #
Wilmington 7.328
Houston 6.965
Woodbridge 6.868
Fairfield 909
Chandler 510
Ann Arbor 429
Dublin 390
Ashburn 381
Seattle 340
Medford 298
Cambridge 294
Jacksonville 263
Rome 260
New York 210
Dearborn 185
Beijing 161
Milan 147
Lawrence 138
Dong Ket 94
San Diego 85
Singapore 82
Menlo Park 59
Moscow 55
Phoenix 34
Redwood City 28
Catania 26
Mülheim 26
Seoul 26
Verona 26
London 25
Nanjing 22
Brussels 21
Toronto 19
Florence 18
Norwalk 18
Turin 18
Napoli 17
Parma 16
Hangzhou 15
Kraków 15
Guangzhou 14
Hong Kong 14
Naples 13
Creede 12
Falls Church 12
Zurich 12
Boardman 11
Monmouth Junction 11
Ottawa 11
Perugia 11
Taipei 11
University Park 11
Messina 10
Mountain View 10
Bologna 9
Kunming 9
Zhengzhou 9
Bangalore 8
Chengdu 8
Dallas 8
Hefei 8
Redmond 8
Saint Petersburg 8
San Francisco 8
San Mateo 8
Tehran 8
Frankfurt am Main 7
Genoa 7
Lisbon 7
Miami 7
Palermo 7
Pomezia 7
Rho 7
Santa Clara 7
Amsterdam 6
Brescia 6
Los Angeles 6
Roebling 6
São Paulo 6
Bari 5
Cattolica 5
Charsadda 5
Duncan 5
Galway 5
Genova 5
Helsinki 5
Jinan 5
Locate Varesino 5
Madrid 5
Padova 5
Scandicci 5
Shanghai 5
Spoltore 5
Trento 5
Washington 5
Andover 4
Catanzaro 4
Ciciliano 4
Durban 4
Fuzhou 4
Totale 27.269
Salva come PNG Salva come JPEG
Nome #
Extending influenza vaccination to individuals aged 50-64: a budget impact analysis 501
Strategie e performance nel mercato farmaceutico italiano: un'analisi empirica 479
General disease costing principles 420
A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache 419
Economic Burden of Human Papillomavirus-Related Diseases in Italy 419
Economic effects of treatment of chronic kidney disease with low-protein diet 412
Health Utilities Lost and Risk Factors Associated With HPV-induced Diseases in Men and Women: The HPV Italian Collaborative Study Group 410
Governance of preventive health intervention and on time verification of its efficiency: the GIOVE study 403
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab. 397
Rapporto CEIS-Sanità 2006: il governo del sistema sanitario: complessità e prospettive dei nuovi assetti istituzionali 395
Scenari e strategie nel settore farmaceutico 395
Cost-effectiveness analysis for the treatment of chronic kidney disease with low-protein diet 387
A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache 386
The perception of corruption in health: AutoCM methods for an international comparison 382
Rapid responses to: Letter to the Editor, by L. Garattini and G. Casadei [Vaccine 27 (38) (20 August 2009) 5171] 380
The new perspectives of italian national health service 377
Towards the eradication of HPV infection through universal specific vaccination 376
A One-Year Economic Evaluation of Botulinum Toxin Type A Treatment of Chronic Tension-type Headaches: Part II 374
Hospital costs incurred by the Italian national health service for invasive cervical cancer 374
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory 373
Health and economic impact associated with a quadrivalent HPV vaccine in Italy 369
Improving care through health economics analyses: cost of illness and headache 367
Oral vs injection therapy in the treatment of metastatic colorectal cancer. a cost minimization analysis in a public hospital of the lazio region [Terapia orale vs terapia infusionale nel trattamento del cancro del colon retto localmente avanzato o avanzato analisi di minimizzazione dei costi presso una struttura ospedaliera della regione lazio] 364
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 363
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study 362
Rapporto CEIS-Sanità 2005: sette parole chiave del SSN 360
Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline 357
Pilot evaluation of indirect costs and the impact of bipolar disorder type I 355
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional healthcare providers 352
Rapporto CEIS-Sanità 2003: bisogni, risorse e nuove strategie 348
Rapporto CEIS-Sanità 2004: sostenibilità, equità e ricerca dell'efficienza 348
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy 348
Cost of poor adherence to anti-hypertensive therapy in five European countries 342
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study 341
Public health value of universal HPV vaccination 334
The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility. 332
Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis 328
Economic evaluation of spondyloarthritis: Economic impact of diagnostic delay in Italy 326
Rapporto CEIS-Sanità 2007: responsabilità, autonomia, sussidiarietà, integrazione, valutazione, empowerment: 6 "nuove" parole chiave per il futuro del SSN 325
Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients 325
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation 324
The Welfare States in a United Europe 320
Joint Procurement and the EU perspective. In Law and Economics of Public Procurement reforms 319
Improving care through health economics analyses: cost of illness and headache (general disease costing principles) 317
Anti-HPV vaccination in Italy: a review of recent economic data for Italy 314
Equità e fairness del servizio sanitario nazionale italiano 314
Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?: An approach based on Artificial Neural Networks 314
Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study 311
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study 309
Il settore industriale sanitario in Italia 308
Dinamiche e determinanti del settore farmaceutico in Europa 305
Criteri per l'allocazione regionale delle risorse per la sanità: riflessioni sul caso italiano 303
The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports. 302
Primary Biliary Cholangitis: advances in management and treatment of the disease 298
Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study. [Costi diretti e indiretti associati a malattie allergiche respiratorie in Italia. Uno studio probabilistico di cost of illness] 295
Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region 293
Time trade-off procedure for measuring health utilities loss with human papillomavirus–induced diseases: a multicenter, retrospective, observational pilot study in Italy 292
Health policy model: Long-term Predictive results associated with the management of hepatitis C virus-induced diseases in Italy 280
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada 279
PDB51. Direct and indirect cost of diabetes in italy: A prevalence probabilistic approach 278
Human papillomavirus 9-valent vaccine for cancer prevention: A systematic review of the available evidence 277
Dimensioni e tendenze del mercato farmaceutico in Italia (1980/1997) 276
A novel method to value real options in health care: The case of a multicohort human papillomavirus vaccination strategy 275
Fraud and Corruption in Healthcare: Recognizing Such Phenomena to Combat Them. 268
Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanerceptt 265
null 263
Early treatment in HIV patients: a cost–utility analysis from the Italian perspective 253
Analisi di impatto di budget di pasireotide in pazienti con Acromegalia nella prospettiva del Servizio Sanitario Nazionale 251
Il settore industriale farmaceutico italiano 250
Introduzione 250
Economics of Headache 244
Strategie e performance delle grandi aziende farmaceutiche in Italia (1979-2001) 239
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 233
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy 226
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 212
The economic impact of biosimilars in Italy: a scenario analysis 205
Erratum to: Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory 203
Economic burden of HPV9-related diseases: a real-world cost analysis from Italy 198
Screening strategies for Hepatitis C Virus elimination in Italy 198
Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. Human menopausal gonadotropin for women undergoing IVF 195
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma 192
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 190
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer 185
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy 174
Budget Impact Analysis della gestione dell'agitazione psicomotoria con loxapina inalatoria in Italia. 173
HPV Vaccination Concepts in the Reality of Today 171
Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries 158
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group 148
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy 148
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 145
Analisi di Budget Impact su modelli di acquisto e gestione degli ausili per l’incontinenza urinaria a confronto 142
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries 139
Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective 135
PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: A REAL-WORLD-BASED ANALYSIS FROM PITER DATA 133
. The burden of atopic dermatitis in adults in Italy 132
Estimation of the number of HCV-positive patients in Italy 131
La corruzione in sanità: i nuovi strumenti per individuarla e contrastarla 113
Invecchiamento della popolazione e sostenibilità del SSN:il ruolo della Health Technology Assessment (HTA) per la valutazione tecnica, economica ed organizzativa della Sanità del futuro 112
Burden economico della neuropatia ottica ereditaria di Leber (LHON) in Italia: stima dei costi indiretti e diretti a carico del paziente. 110
The burden of atopic dermatitis in adults in Italy 103
Totale 28.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.012 0 592 769 837 795 887 750 736 860 686 573 527
2020/20215.494 521 537 631 569 760 621 640 500 147 145 241 182
2021/20221.610 77 131 140 88 71 88 149 143 95 84 149 395
2022/20231.734 178 113 51 201 154 407 165 109 148 33 120 55
2023/2024966 89 44 69 33 80 233 66 50 63 52 46 141
2024/2025160 117 43 0 0 0 0 0 0 0 0 0 0
Totale 30.621